Feminade Inc.

Feminade is a pioneering startup dedicated to improving hormone health for women. The company offers advanced diagnostic testing and telehealth services, connecting women with functional medicine doctors and hormone experts to identify the root causes of their symptoms and develop personalized care plans. This is particularly significant as women's hormones remain one of the most misunderstood and under-researched areas of women's health.

One of Feminade's key initiatives involves the construction of the first real-world AI database and analytics tool to comprehend the impacts of hormonal imbalances on the development of chronic diseases such as PCOS, autoimmune disorders, cancer, infertility, menopause, and more. This data-driven approach enables Feminade to develop and deliver innovative healthcare solutions aimed at preventing and treating such illnesses.

Founded in 2020 and headquartered in the United States, Feminade received a grant investment from EndeavorLAB on 27 June 2023. Ultimately, Feminade envisions a world where women's symptoms are no longer dismissed, empowering women to have full autonomy over their health.